Nordly S, Jørgensen T, Andreasen A H, Hermann N, Mortensen H B
Department of Paediatrics, Glostrup University Hospital, Denmark.
Diabet Med. 2003 Jul;20(7):568-74. doi: 10.1046/j.1464-5491.2003.00983.x.
To describe the management of children and adolescents with Type 1 diabetes mellitus in Denmark.
Quality indicators with standards of childhood diabetes management were chosen based on international and national guidelines. Data originated from the nation-wide Danish Registry for Childhood Diabetes and two questionnaires: one questionnaire was sent to all children with diabetes (response rate 78%, n=1335) and the other was sent to the 19 centres in Denmark treating these children (response rate 100%). Simultaneously, the children were asked to take a blood sample for central HbA1c-analysis (normal range 4.3-5.8, mean 5.1%).
Most children were managed at centres which complied with the standards for the process indicators for good diabetes management, but not with the standards for most structure and outcome indicators. Only one third of the children reached the treatment target for HbA1c. Their mean HbA1c-level increased gradually from ages 4-14 without significant difference between genders. The youngest children had the lowest HbA1c (mean 8.2%) and the lowest rate of severe hypoglycaemic events (4.6 events per 100 patient years). The subgroup of children without any hypoglycaemic events had the significantly lowest mean HbA1c-level (8.6%, P=0.028).
The Danish Registry for Childhood Diabetes provided useful data for quality improvement, but had to be supplemented with data from questionnaires on the structure and process indicators. Outcome of paediatric diabetes management in Denmark was unsatisfactory. Centres need feedback on ways to improve care to lower the children's risk of developing severe diabetes complications.
描述丹麦1型糖尿病儿童及青少年的管理情况。
根据国际和国家指南选择儿童糖尿病管理标准的质量指标。数据来源于丹麦全国儿童糖尿病登记处以及两份调查问卷:一份问卷发送给所有糖尿病患儿(回复率78%,n = 1335),另一份发送给丹麦治疗这些患儿的19个中心(回复率100%)。同时,要求患儿采集血样进行糖化血红蛋白(HbA1c)中心分析(正常范围4.3 - 5.8,平均5.1%)。
大多数患儿在符合良好糖尿病管理过程指标标准的中心接受管理,但不符合大多数结构和结果指标的标准。只有三分之一的患儿达到了HbA1c治疗目标。他们的平均HbA1c水平从4至14岁逐渐升高,不同性别之间无显著差异。最年幼的患儿HbA1c最低(平均8.2%),严重低血糖事件发生率也最低(每100患者年4.6次事件)。无任何低血糖事件的患儿亚组平均HbA1c水平显著最低(8.6%,P = 0.028)。
丹麦儿童糖尿病登记处为质量改进提供了有用数据,但必须补充关于结构和过程指标的调查问卷数据。丹麦儿童糖尿病管理的结果不尽人意。各中心需要关于改善护理方法的反馈,以降低患儿发生严重糖尿病并发症的风险。